EMA Says Tepezza Received Positive CHMP Opinion For Treatment Of Adults With Moderate To Severe Thyroid Eye Disease
ReutersApr 25, 2025 2:19 PM
April 25 (Reuters) - EMA:
EMA SAYS CHMP WILL RE-EXAMINE OPINION ADOPTED FOR MARKETING AUTHORISATION HOLDER FOR KISUNLA (DONANEMAB)
EMA SAYS CHMP RECOMMENDS CONDITIONAL MARKETING AUTHORISATION FOR DUVYZAT (GIVINOSTAT), AS TREATMENT FOR DMD IN PATIENTS FROM AGE SIX WHO CAN WALK
EMA SAYS TEPEZZA (TEPROTUMUMAB) RECEIVED POSITIVE OPINION FROM CHMP FOR TREATMENT OF ADULTS WITH MODERATE TO SEVERE THYROID EYE DISEASE
EMA SAYS SEPHIENCE (SEPIAPTERIN) GOT POSITIVE OPINION FROM CHMP FOR TREATMENT OF HYPERPHENYLALANINAEMIA IN ADULTS & CHILDREN WITH PHENYLKETONURIA
EMA SAYS CHMP RECOMMENDED GRANTING CONDITIONAL MARKETING AUTHORISATION FOR ZIIHERA (ZANIDATAMAB)
Source text: [ID:]
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
After $20B Debt Sale, Google’s Rare 100-Year Bond Sparks Scrutiny: Has AI Drained the Tech Giant’s Coffers?
TradingKey - According to a Financial Times report, Google parent Alphabet (GOOG)(GOOGL) is planning to issue bonds denominated in British pounds and Swiss francs, which may include the first 100-year GBP bond of this century.TradingKey
12 hours ago
Investing in Health Stock: Will GLP-1 Pill Copycat Restrictions Derail Hims & Hers? Is HIMS Still a Good Choice in 2026?
Hims & Hers' subscription-based business model, coupled with tailored treatment regimens, allows users to maintain lasting engagement, a critical aspect of the company’s growth narrative and a reason why some see Hims & Hers stock as a play on long-term digital health as opposed to a traditional phaTradingKey
15 hours ago
What Hidden Concerns Arise From Sanae Kaoshi’s Election Victory? Japanese Government Bonds Suffered a Massive Sell-off To Protect Their Value? Will Bond Prices Continue To Fall in 2026?
TradingKey - Recently, long-term Japanese government bonds (JGBs) have faced a sustained sell-off, causing prices to plunge and yields to surge to nearly 27-year highs. On January 20, the 10-year JGB yield climbed to 2.330% at one point, marking its highest level since February 1999. On February 9,TradingKey
16 hours ago
SpaceX IPO Approaching: Will EchoStar Be a Good Buy in 2026?
TradingKey - Today, EchoStar (SATS) is a hybrid story around legacy consumer communications and a high-profile private space play. As a result of its merger with DISH, the company offers satellite TV services and the wireless brand Boost Mobile, in addition to spectrum assets and wholesale network aTradingKey
18 hours ago
